Circulating Tumor Cells for Cancer Diagnosis and Prognosis

A postdoctoral position in translational medicine is available immediately at Scripps Research Institute.  The melanoma fluid biopsy project will be collaboration between Dr. Peter Kuhn and Dr. Jeanne Loring at Scripps Research, and Dr. Kelly Bethel at Scripps Clinic, who are well-established investigators in rare cell biology, stem cell biology, and hematopathology.  A  highly qualified postdoctoral fellow will develop an assay to identify and distinguish circulating melanoma cells (CMCs) from the millions of normal cells already present in the blood.  An assay will be adapted from an already established circulating tumor cell assay used in the Kuhn Laboratory to identify tumor cells in the blood of patients with epithelial cancers. 

This individual will have completed a Ph.D. or MD/PhD on a related topic and preferably a year of postdoctoral research, experience with immunofluorescence staining assays, fluorescent microscopy, fluorescence in-situ hybridization, and mammalian cell culture.  Experience with stem cells is also highly desirable. Suitable candidates must also have excellent organizational and communication skills and must be highly motivated individuals.  Applicants should send a cover letter indicating research skills, experience, goals, and contact information (email address and phone number), curriculum vitae and a minimum of three references to: Peter Kuhn, PhD (enunez@scripps.edu)

 

For related work, please see http://kuhn.scripps.edu